Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04929951 · ClinicalTrials.gov registry record · Phase 1
The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis
A Phase 1 study of Shoulder Pain and Osteoarthritis Shoulder, sponsored by Stanford University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT04929951: Recruiting Phase 1 study of Shoulder Pain and Osteoarthritis Shoulder, sponsored by Stanford University.
NCT04929951 is a Phase 1 study of Shoulder Pain and Osteoarthritis Shoulder that is actively recruiting participants, run by Stanford University. The registered enrollment target is 48 participants, below the 99-participant average among 27 other Shoulder Pain trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04929951, a Phase 1 study of Shoulder Pain and Osteoarthritis Shoulder, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a non-surgical trial comparing the clinical and functional outcomes of patients with osteoarthritis treated with Intra-articular injection of Micro Fragmented Adipose Tissue versus conventional therapy of intra-articular injection of corticosteroid.
Primary Outcome
Patient reported outcome measure that reports shoulder pain and shoulder functionality
Conditions Studied
Interventions
- BIOLOGICAL Micro Fragmented Adipose Tissue
- BIOLOGICAL Corticosteroid injection
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2022-07-28 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 1 |
What NCT04929951 shows while recruiting
NCT04929951 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 99-participant average among 27 other Shoulder Pain trials with a reported enrollment target (52% lower).
The record links to 2 conditions, with Shoulder Pain appearing as the primary indexed condition, and to 2 interventions - of which Micro Fragmented Adipose Tissue is the first listed.
NCT04929951 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04929951 about?
NCT04929951 is a clinical study titled "The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis". This is a non-surgical trial comparing the clinical and functional outcomes of patients with osteoarthritis treated with Intra-articular injection of Micro Fragmented Adipose Tissue versus conventional therapy of intra-articular injection of corticosteroid.
What is the current status of trial NCT04929951?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2022-07-28. Estimated completion is 2027-12-31.
What conditions does trial NCT04929951 study?
This clinical trial studies the following conditions: Shoulder Pain, Osteoarthritis Shoulder.
What interventions are being tested in trial NCT04929951?
The interventions under investigation include: Micro Fragmented Adipose Tissue (BIOLOGICAL), Corticosteroid injection (BIOLOGICAL).
Who is sponsoring clinical trial NCT04929951?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04929951 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shoulder Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04929951's enrollment target sits among peer trials
48 16th of 27 higher than 12 of 27 other Shoulder Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Shoulder Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Platelet-Rich Plasma Therapy for Shoulder Pain in Persons With Spinal Cord Injury
COMPLETED · Phase 1
-
Shoulder RFA Pilot Study
RECRUITING
-
MDR - Comprehensive Primary Revision Stems PMCF
RECRUITING
-
Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block
RECRUITING
-
Patient Outcomes Collection: How Can we do Better?
RECRUITING · NA
-
Zimmer Biomet Shoulder Arthroplasty PMCF
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI